Company Overview
About Hippocratic AI
Hippocratic AI is founded in 2023 by Munjal Shah, headquartered in Palo Alto. Builds safety-focused non-diagnostic patient-facing AI agents for post-discharge follow-ups, chronic disease management, pre-op check-ins, scheduling, and medication adherence. Does not prescribe or diagnose.
Business Model & Competitive Advantage
Raised $404M including $126M Series C (November 2025) at $3.5B from Avenir Growth, a16z, General Catalyst, Kleiner Perkins, and Google CapitalG. Polaris 3.0: 4.2 trillion parameters across 22 specialized LLMs, 99.38% clinical accuracy. Integrates with Epic, Cerner, Salesforce.
Competitive Landscape 2025–2026
50+ health systems/payors/pharma across 6 countries. 1,000+ clinical use cases. 115M+ patient interactions with no safety issues. 8.95/10 patient satisfaction. Planned strategic M&A to expand capabilities.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Hippocratic AI is an established challenger with significant market presence and competitive offerings in Healthcare Tech.
Enterprise Scale
With $3500M in revenue, Hippocratic AI operates at enterprise scale with proven market validation.
Frequently Asked Questions
Compare Hippocratic AI with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Start Comparison →Claim This Profile
Are you from Hippocratic AI? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Hippocratic AI Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Hippocratic AI vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →